Geodon Im 20mg/ml Powder for solution for injection.
PDF Leaflet Revision Date: 28 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of acute agitation in schizophrenic patients.
Dosage (summary)
10-20 mg IM every 2 hours, max 40 mg/day.
Onset of Action / Duration
Onset: 30-60 mins, Duration: Not specified
Special Populations
- Elderly population
- Renal impairment
- Hepatic impairment
- Paediatric population
Pregnancy & Breastfeeding
Not recommended; teratogenicity in animal studies.
Key Drug Interactions
- Class IA and III anti-dysrhythmics
- CNS depressants
- Serotonergic medicines
Contraindications
- Hypersensitivity to ziprasidone
- QT interval prolongation
- Recent myocardial infarction
- Uncompensated heart failure
Common side effects
- Nausea
- Sedation
- Dizziness
- Injection site pain
- Headache
Counselling Points
- Avoid driving until effects are known.
- Monitor for signs of hyperglycaemia.
- Report any severe skin reactions.
Serious warnings
- QT interval prolongation
- Neuroleptic malignant syndrome
- Severe cutaneous adverse reactions
- Increased mortality in elderly patients with dementia-related psychosis
Important Disclaimer
The Geodon Im 20mg/ml Powder for solution for injection. professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
